vs
BALCHEM CORP（BCPC）与RENASANT CORP（RNST）财务数据对比。点击上方公司名可切换其他公司
RENASANT CORP的季度营收约是BALCHEM CORP的1.0倍（$273.8M vs $263.6M），RENASANT CORP净利率更高（32.2% vs 14.9%，领先17.3%），过去两年RENASANT CORP的营收复合增速更高（29.3% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
瑞耐桑特银行是美国密西西比州图珀洛的区域商业金融机构，母公司为瑞耐桑特公司，在阿拉巴马、佛罗里达、佐治亚、密西西比、路易斯安那、田纳西、北卡罗来纳、南卡罗来纳八州拥有280多家分支机构，旗下还运营内容平台“瑞耐桑特国度”，发布博客及节目内容。
BCPC vs RNST — 直观对比
营收规模更大
RNST
是对方的1.0倍
$263.6M
净利率更高
RNST
高出17.3%
14.9%
两年增速更快
RNST
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $273.8M |
| 净利润 | $39.2M | $88.2M |
| 毛利率 | 35.6% | — |
| 营业利润率 | 19.8% | — |
| 净利率 | 14.9% | 32.2% |
| 营收同比 | 9.8% | — |
| 净利润同比 | 16.8% | 112.5% |
| 每股收益（稀释后） | $1.21 | $0.94 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCRNST
| Q1 26 | — | $273.8M | ||
| Q4 25 | $263.6M | $278.4M | ||
| Q3 25 | $267.6M | $269.5M | ||
| Q2 25 | $255.5M | $267.2M | ||
| Q1 25 | $250.5M | $170.7M | ||
| Q4 24 | $240.0M | $167.1M | ||
| Q3 24 | $239.9M | $220.3M | ||
| Q2 24 | $234.1M | $163.8M |
净利润BCPCRNST
| Q1 26 | — | $88.2M | ||
| Q4 25 | $39.2M | $78.9M | ||
| Q3 25 | $40.3M | $59.8M | ||
| Q2 25 | $38.3M | $1.0M | ||
| Q1 25 | $37.1M | $41.5M | ||
| Q4 24 | $33.6M | $44.7M | ||
| Q3 24 | $33.8M | $72.5M | ||
| Q2 24 | $32.1M | $38.8M |
毛利率BCPCRNST
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
营业利润率BCPCRNST
| Q1 26 | — | — | ||
| Q4 25 | 19.8% | 34.8% | ||
| Q3 25 | 20.4% | 27.9% | ||
| Q2 25 | 20.1% | 1.0% | ||
| Q1 25 | 20.4% | 30.4% | ||
| Q4 24 | 19.8% | 29.8% | ||
| Q3 24 | 20.0% | 44.2% | ||
| Q2 24 | 19.6% | 29.6% |
净利率BCPCRNST
| Q1 26 | — | 32.2% | ||
| Q4 25 | 14.9% | 28.4% | ||
| Q3 25 | 15.1% | 22.2% | ||
| Q2 25 | 15.0% | 0.4% | ||
| Q1 25 | 14.8% | 24.3% | ||
| Q4 24 | 14.0% | 26.8% | ||
| Q3 24 | 14.1% | 32.9% | ||
| Q2 24 | 13.7% | 23.7% |
每股收益（稀释后）BCPCRNST
| Q1 26 | — | $0.94 | ||
| Q4 25 | $1.21 | $0.78 | ||
| Q3 25 | $1.24 | $0.63 | ||
| Q2 25 | $1.17 | $0.01 | ||
| Q1 25 | $1.13 | $0.65 | ||
| Q4 24 | $1.03 | $0.70 | ||
| Q3 24 | $1.03 | $1.18 | ||
| Q2 24 | $0.98 | $0.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $1.2B |
| 总债务越低越好 | — | $806.2M |
| 股东权益账面价值 | $1.3B | $3.9B |
| 总资产 | $1.7B | $27.1B |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资BCPCRNST
| Q1 26 | — | $1.2B | ||
| Q4 25 | $74.6M | $1.1B | ||
| Q3 25 | $65.1M | $1.1B | ||
| Q2 25 | $65.4M | $1.4B | ||
| Q1 25 | $49.9M | $1.1B | ||
| Q4 24 | $49.5M | $1.1B | ||
| Q3 24 | $73.7M | $1.3B | ||
| Q2 24 | $63.7M | $851.9M |
总债务BCPCRNST
| Q1 26 | — | $806.2M | ||
| Q4 25 | — | $499.8M | ||
| Q3 25 | — | $558.9M | ||
| Q2 25 | — | $557.0M | ||
| Q1 25 | — | $433.3M | ||
| Q4 24 | — | $430.6M | ||
| Q3 24 | — | $433.2M | ||
| Q2 24 | — | $428.7M |
股东权益BCPCRNST
| Q1 26 | — | $3.9B | ||
| Q4 25 | $1.3B | $3.9B | ||
| Q3 25 | $1.3B | $3.8B | ||
| Q2 25 | $1.3B | $3.8B | ||
| Q1 25 | $1.2B | $2.7B | ||
| Q4 24 | $1.1B | $2.7B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $1.1B | $2.4B |
总资产BCPCRNST
| Q1 26 | — | $27.1B | ||
| Q4 25 | $1.7B | $26.8B | ||
| Q3 25 | $1.7B | $26.7B | ||
| Q2 25 | $1.7B | $26.6B | ||
| Q1 25 | $1.6B | $18.3B | ||
| Q4 24 | $1.6B | $18.0B | ||
| Q3 24 | $1.6B | $18.0B | ||
| Q2 24 | $1.6B | $17.5B |
负债/权益比BCPCRNST
| Q1 26 | — | 0.21× | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.18× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BCPCRNST
| Q1 26 | — | — | ||
| Q4 25 | $67.3M | $271.5M | ||
| Q3 25 | $65.6M | $135.5M | ||
| Q2 25 | $47.3M | $-77.3M | ||
| Q1 25 | $36.5M | $106.2M | ||
| Q4 24 | $52.3M | $106.4M | ||
| Q3 24 | $51.3M | $-1.7M | ||
| Q2 24 | $45.0M | $-49.1M |
自由现金流BCPCRNST
| Q1 26 | — | — | ||
| Q4 25 | — | $237.8M | ||
| Q3 25 | — | $120.1M | ||
| Q2 25 | — | $-87.5M | ||
| Q1 25 | — | $101.3M | ||
| Q4 24 | — | $92.8M | ||
| Q3 24 | — | $-5.3M | ||
| Q2 24 | — | $-52.6M |
自由现金流率BCPCRNST
| Q1 26 | — | — | ||
| Q4 25 | — | 85.4% | ||
| Q3 25 | — | 44.6% | ||
| Q2 25 | — | -32.7% | ||
| Q1 25 | — | 59.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | -2.4% | ||
| Q2 24 | — | -32.1% |
资本支出强度BCPCRNST
| Q1 26 | — | — | ||
| Q4 25 | — | 12.1% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 2.1% |
现金转化率BCPCRNST
| Q1 26 | — | — | ||
| Q4 25 | 1.72× | 3.44× | ||
| Q3 25 | 1.63× | 2.27× | ||
| Q2 25 | 1.23× | -75.92× | ||
| Q1 25 | 0.98× | 2.56× | ||
| Q4 24 | 1.56× | 2.38× | ||
| Q3 24 | 1.52× | -0.02× | ||
| Q2 24 | 1.40× | -1.26× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
RNST
| Net Interest Income | $223.6M | 82% |
| Noninterest Income | $50.3M | 18% |
